l9n/ Connecticut

2003 Regular Session

Senate Bill 1119

AN ACT CONCERNING THE DISCLOSURE OF PHARMACEUTICAL MARKETING AND ADVERTISING COSTS.

Did not become law. It stopped in the Senate's Appropriations Committee on May 13, 2003. The 2003 session has ended.

What it does

The synopsis the General Assembly published with the bill.

To require pharmaceutical companies to disclose to the Department of Public Health all advertising and marketing costs associated with each prescription drug sold in the state.

Sponsors

Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.

In the Senate

1 co-sponsor

Edith G. Prague

Its course

March 12 to May 13, 2003, on one scale. In the top row each mark is a day something happened; taller marks are busier days.

Each committee stop sits inside its chamber.

Every action11 actions on 7 days

In the SenateMar 12 to May 13 · stopped62 days

Public Health CommitteeMar 12 to Apr 827 days

Appropriations CommitteeMay 7 to May 13 · stopped6 days

Text

Each version as the General Assembly printed it.

l9n doesn't hold this bill's text yet.

What happened

In l9n's words, one line for each step. Every action as the General Assembly published it is below.

In the Senate Mar 12 – May 7

  1. Mar 12Introduced and sent to Public Health Committee
  2. Mar 14Heard in Public Health Committee
  3. Apr 8Public Health Committee recommended a substitute for it
  4. May 7Sent to Appropriations Committee
All 11 actions, as published
  1. Mar 12REF. TO JOINT COMM. ONBoth houses
  2. Mar 14PUBLIC HEARINGBoth houses
  3. Apr 8FILED WITH LCOBoth houses
  4. Apr 8Joint Favorable SubstituteBoth houses
  5. Apr 17REFERRED TO OLR, OFABoth houses
  6. Apr 24RPTD. OUT OF LCOBoth houses
  7. Apr 24FAV. RPT., TAB. FOR CAL., SEN.Senate
  8. Apr 24SENATE CALENDAR NUMBERSenate
  9. Apr 24FILE NO.Both houses
  10. May 7REF. BY SEN. TO COMM. ONSenate
  11. May 13MOTION FAILEDSenate